Multiple sclerosis management - A changing landscape 2013: Proceedings of the meeting: Multiple sclerosis management - A changing landscape 2013, held on 26-27 April 2013 in Vienna, Austria

Per Soelberg Sørensen, Massimo Filippi, Wolfgang Brück

Research output: Contribution to journalArticle

Abstract

The aims of this educational meeting, held in Vienna, Austria, were to explore the significant advances that have occurred in multiple sclerosis (MS) management over the past two decades, to highlight modern-day perspectives and challenges and to consider the impact of the new oral first-line treatments expected to enter the MS market shortly. The meeting was attended by 372 delegates with neurological interests from 30 countries and was opened by Per Soelberg Sørensen (Copenhagen, Denmark).

Original languageEnglish
Pages (from-to)105-114
Number of pages10
JournalEuropean Neurological Review
Volume8
Issue number2
Publication statusPublished - 2013

Fingerprint

Austria
Multiple Sclerosis
Denmark

Keywords

  • Individualised therapy
  • Magnetic resonance imaging
  • Multiple sclerosis
  • Oral agents
  • Pathophysiology
  • Role of injectable agents

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

@article{670ebe715ede4c229617278672f4f7df,
title = "Multiple sclerosis management - A changing landscape 2013: Proceedings of the meeting: Multiple sclerosis management - A changing landscape 2013, held on 26-27 April 2013 in Vienna, Austria",
abstract = "The aims of this educational meeting, held in Vienna, Austria, were to explore the significant advances that have occurred in multiple sclerosis (MS) management over the past two decades, to highlight modern-day perspectives and challenges and to consider the impact of the new oral first-line treatments expected to enter the MS market shortly. The meeting was attended by 372 delegates with neurological interests from 30 countries and was opened by Per Soelberg S{\o}rensen (Copenhagen, Denmark).",
keywords = "Individualised therapy, Magnetic resonance imaging, Multiple sclerosis, Oral agents, Pathophysiology, Role of injectable agents",
author = "S{\o}rensen, {Per Soelberg} and Massimo Filippi and Wolfgang Br{\"u}ck",
year = "2013",
language = "English",
volume = "8",
pages = "105--114",
journal = "European Neurological Review",
issn = "1758-3837",
publisher = "Touch Briefings",
number = "2",

}

TY - JOUR

T1 - Multiple sclerosis management - A changing landscape 2013

T2 - Proceedings of the meeting: Multiple sclerosis management - A changing landscape 2013, held on 26-27 April 2013 in Vienna, Austria

AU - Sørensen, Per Soelberg

AU - Filippi, Massimo

AU - Brück, Wolfgang

PY - 2013

Y1 - 2013

N2 - The aims of this educational meeting, held in Vienna, Austria, were to explore the significant advances that have occurred in multiple sclerosis (MS) management over the past two decades, to highlight modern-day perspectives and challenges and to consider the impact of the new oral first-line treatments expected to enter the MS market shortly. The meeting was attended by 372 delegates with neurological interests from 30 countries and was opened by Per Soelberg Sørensen (Copenhagen, Denmark).

AB - The aims of this educational meeting, held in Vienna, Austria, were to explore the significant advances that have occurred in multiple sclerosis (MS) management over the past two decades, to highlight modern-day perspectives and challenges and to consider the impact of the new oral first-line treatments expected to enter the MS market shortly. The meeting was attended by 372 delegates with neurological interests from 30 countries and was opened by Per Soelberg Sørensen (Copenhagen, Denmark).

KW - Individualised therapy

KW - Magnetic resonance imaging

KW - Multiple sclerosis

KW - Oral agents

KW - Pathophysiology

KW - Role of injectable agents

UR - http://www.scopus.com/inward/record.url?scp=84893059932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893059932&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84893059932

VL - 8

SP - 105

EP - 114

JO - European Neurological Review

JF - European Neurological Review

SN - 1758-3837

IS - 2

ER -